Geethal BHH

Prediction of Timely Decaying Efficiency of Factor VIII Replacement Therapy Using Activated Partial Thromboplastin Time (aPTT) Test in Hemophilia A Patients Undergoing Treatment at the National Hospital of Sri Lanka (NHSL)

Zoysa KKP, Geethal BHH, Ratnamalala V & Kottahachchi DU · Asian Hematology Research Journal · 2024

Introduction: Hemophilia A is a genetic disorder caused by Factor VIII deficiency. Prophylactic Factor VIII replacement therapy aims to maintain baseline levels and prevent bleeding. This study aimed to investigate the relationship between Activated Partial Thromboplastin Time (a...